Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG). (Q55044937)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG). |
scientific article |
Statements
1 reference
Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG). (English)
1 reference
Holger Schulz
1 reference
Ute Rehwald
1 reference
Franck Morschhauser
1 reference
Thomas Elter
1 reference
Christoph Driessen
1 reference
Thomas Rüdiger
1 reference
Peter Borchmann
1 reference
Roland Schnell
1 reference
Volker Diehl
1 reference
Andreas Engert
1 reference
Marcel Reiser
1 reference
15 October 2007
1 reference
1 reference
111
1 reference
1
1 reference
109-111
1 reference
Identifiers
1 reference